Press releases

Marlborough, Mass. (January 20, 2015) – Boston Scientific Corporation (NYSE: BSX), a global medical device company headquartered in Marlborough, Massachusetts, will co-sponsor the 2015...

Boston Scientific Corporation (NYSE: BSX) will host and webcast an Investor Day business review meeting for the investment community on Friday, May 1, 2015. The meeting and webcast are scheduled...

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year ended December 31, 2014 on...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2015 in San Francisco. Mike Mahoney, president...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs CEOs Unscripted Healthcare Conference on Tuesday, January 6, 2015 in Boston. Mike Mahoney, president and...

New retrospective data evaluating the Boston Scientific Corporation (NYSE: BSX) Precision Spectra™ Spinal Cord Stimulator (SCS) System demonstrate that the device provided sustained, highly...

Boston Scientific has scored the highest rating of 100 percent in the Human Rights Campaign (HRC) Foundation's 2015 Corporate Equality Index (CEI). The top mark distinguishes the company as one of...

In the first successful U.S. pivotal trial of a bioabsorbable polymer stent, the Boston Scientific (NYSE: BSX) SYNERGY™ Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent...

Boston Scientific Corporation (NYSE: BSX) announces the completion of the first U.S. procedures performed with the Symphion System, designed for the hysteroscopic removal of interuterine fibroids...

Boston Scientific Corporation (NYSE: BSX) announced that its subcutaneous implantable defibrillator (S-ICD System™) will have designated Current Procedural Terminology (CPT®) Category I codes...